Si-Bone (SIBN) Cash from Investing Activities (2017 - 2026)

Si-Bone's (SIBN) quarterly Cash from Investing Activities came in at -$6.2 million in Q1 2026, down 158.63% year-on-year from $10.6 million in Q1 2025, and down 147.84% quarter-over-quarter from $13.0 million in Q4 2025.

Si-Bone (SIBN) Cash from Investing Activities (2017 - 2026) Analysis & Trends

Si-Bone's Cash from Investing Activities history runs 10 years deep, the most recent figure standing at -$6.2 million for Q1 2026.

  • On a quarterly basis, Cash from Investing Activities fell 158.63% year-over-year to -$6.2 million in Q1 2026; TTM through Mar 2026 was -$12.7 million, a 175.13% decrease from a year earlier, with the FY2025 full-year figure at $4.2 million, down 67.04% from the prior year.
  • Cash from Investing Activities declined to -$6.2 million in Q1 2026 per SIBN's latest filing, from $13.0 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $13.0 million in Q4 2025 and bottomed at -$54.9 million in Q3 2023.
  • The 5-year median for Cash from Investing Activities is $2.3 million (2023), against an average of -$3.1 million.
  • Across the five-year window, Cash from Investing Activities tumbled 21349.44% in 2023 and surged 200.35% in 2025, its largest moves.
  • Year by year, Cash from Investing Activities stood at $89000.0 in 2022, then tumbled by 21349.44% to -$18.9 million in 2023, then soared by 122.93% to $4.3 million in 2024, then jumped by 200.35% to $13.0 million in 2025, then tumbled by 147.84% to -$6.2 million in 2026.
  • Per Business Quant, the three latest SIBN Cash from Investing Activities figures stand at -$6.2 million (Q1 2026), $13.0 million (Q4 2025), and -$10.0 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Abbott Laboratories 182.32 Bn 175.02 Bn 6.27 Bn -20.32 Bn
2 Stryker 128.75 Bn 125.88 Bn 3.81 Bn -185.00 Mn
3 Medtronic 107.83 Bn 98.61 Bn 6.41 Bn -917.00 Mn
4 Boston Scientific 67.61 Bn 66.15 Bn 3.61 Bn -591.00 Mn
5 Edwards Lifesciences 48.13 Bn 44.45 Bn 1.29 Bn -92.80 Mn
6 Dexcom 28.26 Bn 27.14 Bn 750.30 Mn -298.50 Mn
7 GE HealthCare Technologies 27.78 Bn 25.50 Bn 1.98 Bn -2.50 Bn
8 Smith & Nephew 26.99 Bn 26.41 Bn - -
9 Koninklijke Philips 23.92 Bn 20.80 Bn 2.07 Bn -475.32 Mn
10 Si-Bone 753.03 Mn 608.35 Mn 41.94 Mn -6.23 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -6.23 Mn
Mar 31, 2026 -6.23 Mn
Dec 31, 2025 13.03 Mn
Dec 31, 2025 13.03 Mn
Sep 30, 2025 -10.03 Mn
Sep 30, 2025 -10.03 Mn
Jun 30, 2025 -9.47 Mn
Jun 30, 2025 -9.47 Mn
Mar 31, 2025 10.63 Mn
Mar 31, 2025 10.63 Mn
Dec 31, 2024 4.34 Mn
Dec 31, 2024 4.34 Mn
Sep 30, 2024 3.77 Mn
Sep 30, 2024 3.77 Mn
Jun 30, 2024 -1.83 Mn
Jun 30, 2024 -1.83 Mn
Mar 31, 2024 6.35 Mn
Mar 31, 2024 6.35 Mn
Dec 31, 2023 -18.91 Mn
Dec 31, 2023 -18.91 Mn